DailyIQ
Last updated 2 minutes ago

CME·CME Group Inc.

$.
-. (-.%)
High
$279.82
Open
$277.42
Market Cap
100.53B
52W High
$329.16
Low
$275.64
P. Close
$277.42
P/E
23.54
52W Low
$257.17
Fwd P/E
21.61
Mean Target
$306.47
Technical Score (1D)
32
SELL
News Sentiment
65
BULLISH
CME Group's Bitcoin futures are now trading 24/7, removing the historical "CME gap" and offering market participants increased flexibility. This continuous trading environment for Bitcoin futures could reduce price discontinuity risks previously associated with weekend closures. Looking ahead, watch for how this enhanced flexibility impacts trading volumes and price discovery in the Bitcoin futures market. In other developments, CME Group's Chairman and CEO, Terry Duffy, is scheduled to present at the Piper Sandler Global Exchange and Fintech Conference on June 4, 2026. This presentation will offer insights into the derivatives marketplace and CME's role in global risk management. Separately, CME Group data confirms that aluminum prices have reached a four-year high, driven by U.S. tariffs and geopolitical events in the Middle East. This surge in aluminum prices, which has seen an 18% climb since late February, highlights the exchange's role in facilitating price discovery for key commodities. The ongoing strength in aluminum prices could continue to support trading activity in related futures contracts.
Earnings Summary
CME Group Inc. is a global marketplace that facilitates the trading of futures and options contracts across various asset classes, including interest rates, equity indexes, foreign exchange, and commodities. As a key player in the financial services sector, specifically within financial data and stock exchanges, CME Group provides essential trading platforms, clearinghouse services, and risk mitigation solutions to a diverse clientele. The company's business model is intrinsically linked to market activity and volatility, serving as a critical infrastructure for global derivatives markets. In its most recent reported quarters, CME demonstrated a pattern of exceeding analyst expectations for Earnings Per Share (EPS). For Q1 2026, the company reported an actual EPS of $3.36 against an estimate of $3.12, and for Q4 2025, actual EPS was $2.77 versus an estimate of $2.77, indicating a slight beat or meeting expectations. Revenue also showed a strong upward trend, with Q1 2026 revenue at $1.88 billion, significantly surpassing the estimate of $1.78 billion. This follows a pattern where revenue for Q4 2025 was $1.65 billion, slightly below the estimate of $1.67 billion. Looking at the historical performance, CME Group has shown a consistent ability to grow its revenue year-over-year, even when EPS performance has been more varied. The company has a track record of beating EPS estimates in recent quarters, with Q1 2026 being a notable outperformance. For instance, the EPS beat in Q1 2026 was significant, and the company has generally met or exceeded analyst revenue forecasts in recent periods. Recent news highlights CME Group's community engagement through its Star Scholars program and its recognition as a volatility shield by investment funds, suggesting resilience. Furthermore, potential legislative changes like the Clarity Act could impact Bitcoin derivatives, while increased activity in SOFR-based derivatives and new integrations with platforms like Kalshi indicate evolving market dynamics and potential for growth. Investors will be watching for continued growth in SOFR derivatives and the impact of regulatory developments on digital asset trading. Key will be the company's ability to capitalize on these evolving market trends and maintain its strong revenue growth trajectory.

EPS

EstBeatMiss
$2.52$2.76$2.99$3.23$3.47Q1'25Q2'25Q3'25Q4'25Q1'26Q2'26
QtrEstActual+/−
Q2'26$2.98 - -
Q1'26$3.12$3.36+7.8%
Q4'25$2.77$2.77-0.0%
Q3'25$2.63$2.68+2.0%
Q2'25$2.94$2.96+0.6%
Q1'25$2.81$2.80-0.3%

Revenue

EstBeatMiss
$1.5B$1.6B$1.7B$1.8B$1.9BQ1'25Q2'25Q3'25Q4'25Q1'26Q2'26
QtrEstActual+/−
Q2'26$1.7B - -
Q1'26$1.8B$1.9B+5.8%
Q4'25$1.7B$1.6B-1.1%
Q3'25 - $1.5B -
Q2'25 - $1.7B -
Q1'25 - $1.6B -

Market Data

CME Stock Snapshot

CME is currently trading at $276.29, giving CME Group Inc. a market cap of 100.53B and a P/E ratio of 23.5. Today's range spans $275.64–$279.82, with shares opening at $277.42 and moving down $1.13 (0.4%) from the prior close. DailyIQ's technical score sits at 32/100 (SELL) with a news sentiment reading of 65/100.

Over the past year CME has traded between $257.17 and $329.16 - the current price is +7.4% off the 52-week low and -16.1% from the high. 22 analysts cover the stock with a Buy consensus and a mean 12-month target of $306.47 (range $230.00–$353.00), implying upside of +10.9%.

CME: large-cap, Financial Services, 100.53B market cap. (P/E: 23.5) Technical score 32/100 (SELL). Sentiment: bullish (65/100). Price: $276.29 (in the lower half of its 52-week range). Range: $257.17–$329.16. The SELL designation at this capitalization tier doesn't mean the stock is uninvestable - it means the risk/reward of buying dips hasn't been restored yet, and patience or an outright hedge is often the better posture until technical conditions improve.

When a large-cap Financial Services name with 100.53B in capitalization prints a SELL signal (32/100) alongside bullish news sentiment (65/100), the risk isn't just price depreciation — it's the loss of institutional sponsorship that makes recovery harder. At $276.29 (in the lower half of its 52-week range in the $257.17–$329.16 range), the structural support levels are where that sponsorship question gets answered.